Wall Street Is Missing the Bigger Picture: Why This Legacy Tech Stalwart Is a Screaming Buy Right Now

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • IBM's software revenue hit $7.05 billion in Q1 2026, up 11%, while mainframe revenue surged 51% as enterprises modernized mission-critical workloads.

  • IBM raised its dividend for the 31st straight year, backed by $14.73 billion in free cash flow that grew 25% in FY2025.

  • IBM's $12.5 billion generative AI book of business and beta of 0.665 compound steady gains while protecting capital when speculative tech trades unwind.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and IBM didn't make the cut. Grab the names FREE today.

Wall Street Is Missing the Bigger Picture: Why This Legacy Tech Stalwart Is a Screaming Buy Right Now

© Anton Vierietin / Shutterstock.com

International Business Machines (NYSE:IBM | IBM Price Prediction) is a stock worth owning for decades because it pairs a 110-year operating history with a recurring-revenue software and infrastructure engine that is now compounding cash at an accelerating pace. IBM is built for retirement portfolios that need durability, income, and survivability across every market cycle, not narrative-driven upside.

Pillar One: A Business Built to Outlast Cycles

IBM has quietly become a software-led company. In Q1 2026, Software revenue reached $7.05 billion, up 11.3%, with Red Hat growing 13%, Data growing 19%, and Automation growing 10%. Infrastructure, often dismissed as legacy, posted 15.3% growth, while IBM Z mainframe revenue surged 51% year over year as enterprises modernized mission-critical workloads. Hybrid cloud architecture and Watsonx integrations are embedded directly into the systems run by financial services firms, healthcare providers, and government agencies, producing the kind of ecosystem lock-in that does not evaporate in a recession. CEO Arvind Krishna told investors, “As clients scale use cases, AI continues to be a tailwind for our global business.”

Pillar Two: Income You Can Actually Plan Around

For an investor who needs predictable cash, IBM is one of the most reliable payers in the market. The board declared its 31st consecutive annual dividend increase on April 22, 2026, lifting the quarterly payout to $1.69 per share. The company has paid consecutive quarterly dividends every year since 1916, a streak that survived the Great Depression, the 1970s stagnation, the dot-com bust, the 2008 financial crisis, and the pandemic. The dividend is well covered: FY2025 free cash flow was $14.73 billion, up 25.29%, and management guided to roughly another $1 billion of free cash flow growth in 2026. The current yield of 2.23% is paired with a forward earnings multiple of 23, modest for a company generating 35.8% return on equity.

Pillar Three: Cycle Survival

IBM’s beta of 0.665 reflects a business insulated from speculative swings. Its customer base, mainframe-anchored enterprises and governments, signs multi-year contracts and rarely rips them out. The generative AI book of business has surpassed $12.5 billion inception-to-date, embedding IBM deeper into client roadmaps. With shareholders’ equity of $32.97 billion, up 22.67%, and an Infrastructure segment profit margin that expanded from 8.6% to 15.8%, the balance sheet and margin structure are strengthening, not weakening.

The One Scenario Where IBM Lags

In a risk-on tech rally led by high-beta semiconductor and pure-play AI names, IBM will look slow. Consulting growth of 4.0% will not match a chipmaker doubling revenue. That is acceptable. A forever holding is designed to compound through the inevitable drawdown that follows a speculation peak. The same low-beta profile that mutes IBM’s upside in a melt-up is what protects capital when leveraged AI trades unwind, and the dividend keeps paying regardless of which narrative the market is chasing that month.

For investors building a long-duration income sleeve, IBM screens as a compounder where reinvested dividends and recurring software cash flow do the heavy lifting over time.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

SJM Vol: 5,284,521
APH Vol: 15,409,690
POOL Vol: 1,587,599
BLDR Vol: 3,106,921
CARR Vol: 10,221,016

Top Losing Stocks

CTRA Vol: 73,319,495
SMCI Vol: 51,854,942
GLW Vol: 16,673,394
NOW Vol: 35,824,740
ENPH Vol: 13,064,701